SEP 23, 2018 01:24 PM PDT

Insulin may be a new Colitis Treatment

WRITTEN BY: Carmen Leitch

Insulin is a necessary medicine for diabetics, but new work shows that insulin may also be used to treat chronic bowel inflammation. Research done by scientists at the University of Copenhagen and Roskilde University found that in a mouse model of colitis when insulin was injected into the rectum, it treated the bowel inflammation that is a part of the disease. The findings have been reported in the Journal of Crohn's and Colitis and are outlined in the following video.

“Our new treatment with insulin on mice shows great potential against chronic bowel inflammation in humans like Colitis Ulcerosa, which causes a lot of people great discomfort. Existing treatments attack the bowel's immune system, dampening it; instead, our method strengthens the bowel cells' own defense. It appears to work equally well, and it can probably be used in combination with existing treatments,” said Jørgen Olsen, co-inventor of the treatment and a professor at the Department of Cellular and Molecular Medicine, University of Copenhagen.

Colitis Ulcerosa is a chronic disorder that can cause aching and cramping, bloody diarrhea, anemia, and weight loss. 

The current treatment has not helped people retain weight. After assessing their mouse model, the scientists found that in mice that received the insulin treatment, fifteen to twenty percent less weight was lost and they were able to gain weight fifty percent faster.  

The researchers also looked at gene expression patterns, which indicated that the insulin treatment also reduced inflammation. In the treated mice, expression of an inflammation marker, the Cox2 gene, was down fifty percent compared to the control group, which received injections of a salt solution instead of insulin.

The insulin exerts its effect by activating a gene with antioxidant effects in the bowels; it may also protect against inflammation. Because that’s a different mechanism than the current treatment, which acts on the immune system, it may be possible to combine the two treatments.

The researchers are working to bring this drug to the clinic. Because many aspects of this therapy, like rectal injections and the insulin itself, are already approved, it will hopefully be available to patients soon. The researchers have set up a company to test the drug in human trials and have applied for a patent. Research funds will likely be enough to complete the initial phases of safety testing, Olsen said. They are also actively in pursuit of additional funding. 

Learn more about colitis from the video.

Sources: AAAS/Eurekalert! via University of Copenhagen, Journal of Crohn's and Colitis

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 08, 2018
Cell & Molecular Biology
AUG 08, 2018
Changing White Fat to Brown Fat
Not all fat is the same. Brown fat is thought to be fat healthier than white fat....
AUG 13, 2018
Cell & Molecular Biology
AUG 13, 2018
In a First, Stem Cell Therapy for Parkinson's in Human Patients
A clinical trial that is the first of its kind has been started in Japan....
SEP 15, 2018
Videos
SEP 15, 2018
A Hangover Cure in a Pill
A night of drinking can lead to a morning of regret for many people, but science is working on a solution for the physical pain....
SEP 17, 2018
Microbiology
SEP 17, 2018
Detecting Dangerous Latent Viruses
Evidence mounts that viruses play a role in disease development....
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
OCT 21, 2018
Genetics & Genomics
OCT 21, 2018
The Genetic Cause of Severe Childhood Epilepsy is Revealed
This work has opened up new therapeutic avenues that the scientists will be exploring....
Loading Comments...